Literature DB >> 22269018

Lower numbers of natural killer T cells in HIV-1 and Mycobacterium leprae co-infected patients.

Karina I Carvalho1, Fernanda R Bruno, Jennifer E Snyder-Cappione, Solange M Maeda, Jane Tomimori, Marilia B Xavier, Patrick A Haslett, Douglas F Nixon, Esper G Kallas.   

Abstract

Natural killer T (NKT) cells are a heterogeneous population of lymphocytes that recognize antigens presented by CD1d and have attracted attention because of their potential role linking innate and adaptive immune responses. Peripheral NKT cells display a memory-activated phenotype and can rapidly secrete large amounts of pro-inflammatory cytokines upon antigenic activation. In this study, we evaluated NKT cells in the context of patients co-infected with HIV-1 and Mycobacterium leprae. The volunteers were enrolled into four groups: 22 healthy controls, 23 HIV-1-infected patients, 20 patients with leprosy and 17 patients with leprosy and HIV-1-infection. Flow cytometry and ELISPOT assays were performed on peripheral blood mononuclear cells. We demonstrated that patients co-infected with HIV-1 and M. leprae have significantly lower NKT cell frequencies [median 0.022%, interquartile range (IQR): 0.007-0.051] in the peripheral blood when compared with healthy subjects (median 0.077%, IQR: 0.032-0.405, P < 0.01) or HIV-1 mono-infected patients (median 0.072%, IQR: 0.030-0.160, P < 0.05). Also, more NKT cells from co-infected patients secreted interferon-γ after stimulation with DimerX, when compared with leprosy mono-infected patients (P = 0.05). These results suggest that NKT cells are decreased in frequency in HIV-1 and M. leprae co-infected patients compared with HIV-1 mono-infected patients alone, but are at a more activated state. Innate immunity in human subjects is strongly influenced by their spectrum of chronic infections, and in HIV-1-infected subjects, a concurrent mycobacterial infection probably hyper-activates and lowers circulating NKT cell numbers.
© 2012 The Authors. Immunology © 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22269018      PMCID: PMC3372761          DOI: 10.1111/j.1365-2567.2012.03563.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  33 in total

Review 1.  NKT cells: facts, functions and fallacies.

Authors:  D I Godfrey; K J Hammond; L D Poulton; M J Smyth; A G Baxter
Journal:  Immunol Today       Date:  2000-11

Review 2.  Gene expression in NKT cells: defining a functionally distinct CD1d-restricted T cell subset.

Authors:  S B Wilson; M C Byrne
Journal:  Curr Opin Immunol       Date:  2001-10       Impact factor: 7.486

3.  Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype.

Authors:  Carlos J Montoya; Juan C Cataño; Zoraida Ramirez; Maria T Rugeles; S Brian Wilson; Alan L Landay
Journal:  Clin Immunol       Date:  2008-03-04       Impact factor: 3.969

4.  Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection.

Authors:  Hans J J van der Vliet; B Mary E von Blomberg; Mette D Hazenberg; Nobusuke Nishi; Sigrid A Otto; Birgit H van Benthem; Maria Prins; Frans A Claessen; Alfons J M van den Eertwegh; Giuseppe Giaccone; Frank Miedema; Rik J Scheper; Herbert M Pinedo
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

5.  Molecular basis for LLT1 protein recognition by human CD161 protein (NKRP1A/KLRB1).

Authors:  Jun Kamishikiryo; Hideo Fukuhara; Yuki Okabe; Kimiko Kuroki; Katsumi Maenaka
Journal:  J Biol Chem       Date:  2011-05-13       Impact factor: 5.157

6.  NKT cells are phenotypically and functionally diverse.

Authors:  K J Hammond; S B Pelikan; N Y Crowe; E Randle-Barrett; T Nakayama; M Taniguchi; M J Smyth; I R van Driel; R Scollay; A G Baxter; D I Godfrey
Journal:  Eur J Immunol       Date:  1999-11       Impact factor: 5.532

7.  Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expression.

Authors:  Jennifer E Snyder-Cappione; Christopher P Loo; Karina I Carvalho; Carlotta Kuylenstierna; Steven G Deeks; Frederick M Hecht; Michael G Rosenberg; Johan K Sandberg; Esper G Kallas; Douglas F Nixon
Journal:  AIDS       Date:  2009-09-24       Impact factor: 4.177

8.  Lower numbers of circulating Natural Killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease.

Authors:  L C Ndhlovu; J E Snyder-Cappione; K I Carvalho; F E Leal; C P Loo; F R Bruno; A R Jha; D Devita; A M Hasenkrug; H M R Barbosa; A C Segurado; D F Nixon; E L Murphy; E G Kallas
Journal:  Clin Exp Immunol       Date:  2009-09-02       Impact factor: 4.330

9.  Inhibition of apoptosis, activation of NKT cell and upregulation of CD40 and CD40L mediated by M. leprae antigen(s) combined with Murabutide and Trat peptide in leprosy patients.

Authors:  Vineeta Chattree; Neena Khanna; Vandana Bisht; D N Rao
Journal:  Mol Cell Biochem       Date:  2007-11-16       Impact factor: 3.396

10.  Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining.

Authors:  Jenny E Gumperz; Sachiko Miyake; Takashi Yamamura; Michael B Brenner
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

View more
  3 in total

1.  Interleukins 15 and 12 in combination expand the selective loss of natural killer T cells in HIV infection in vitro.

Authors:  Venkata Ramanarao Parasa; Anbalagan Selvaraj; Rajasekaran Sikhamani; Alamelu Raja
Journal:  Clin Exp Med       Date:  2014-04-20       Impact factor: 3.984

2.  Invariant Natural Killer T-cell Dynamics in Human Immunodeficiency Virus-associated Tuberculosis.

Authors:  Naomi F Walker; Charles Opondo; Graeme Meintjes; Nishtha Jhilmeet; Jon S Friedland; Paul T Elkington; Robert J Wilkinson; Katalin A Wilkinson
Journal:  Clin Infect Dis       Date:  2020-04-15       Impact factor: 9.079

3.  New Players in the Same Old Game: Disturbance of Group 2 Innate Lymphoid Cells in HIV-1 and Mycobacterium leprae Co-infected Patients.

Authors:  Pedro Henrique Papotto; Solange Maeda; Jane Tomimori; Marília Brasil Xavier; Luiz Vicente Rizzo; Esper Georges Kallas; Karina Inácio Carvalho
Journal:  PLoS Negl Trop Dis       Date:  2015-09-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.